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Arsenicosis leads to various irreversible damages in several organs and is considered to be a               
carcinogen. The effects of chronic arsenic poisoning are a result of an imbalance between              
pro- and antioxidant homeostasis, ​oxidative stress, ​as well as ​DNA and protein damage​.             
Curcumin, the polyphenolic pigment extracted from the rhizome of ​Curcuma longa​, is            
well-known for its pleiotropic medicinal effects. Curcumin has been shown to have            
ameliorative effects in arsenic-induced genotoxicity, nephrotoxicity, hepatotoxicity,       
angiogenesis, skin diseases, reproductive toxicity, neurotoxicity, and immunotoxicity. This         
review aims to summarize the scientific evidence on arsenic toxicity in various organs and              
the ameliorative effects of curcumin on the arsenic toxicity. 
 






Heavy metals are characterized as metallic elements with a relatively high atomic weight             
such as arsenic (As) which may harm living organisms at small concentrations [1]. ​As one of                
the most ​abundant natural elements ​and environmental toxicants, As is considered as a             
critical human health hazard [2]​. Various manifestations of chronic As poisoning           
(arsenicosis) are due to the imbalance between pro- and antioxidant homeostasis and its high              
affinity for thiol groups on proteins. ​As is categorized usually as a metalloid, due to its both                 
metallic and non-metallic features [3].  
As is ubiquitous in the environment, earth’s crust and the biosphere [4, 5]. Human exposure               
to As usually occurs by air, soil, drinking water, inhalation, skin contact during occupational              
situations, contaminated food and medicines [6]. More than 100 million peoples worldwide            
are exposed to a higher than safe recommended level of As in drinking water as               
recommended by the World Health Organization (<10 μg/L) [7]. 
As is water-soluble and exists as elemental (0), trivalent (​+3 oxidation; arsenite), As (III) and               
pentavalent (+5 oxidation; arsenate), As (V). When As combines with elements such as             
oxygen, chlorine and sulfur, it forms the inorganic arsenic (iAs) whereas when it binds with               
hydrogen and carbon, it forms organic As. Notably, As (III) has been considered to be more                
toxic compared to As (V) and iAs are more toxic compared to the organic forms (Figure 1)                 
[8-10]. As (V) is an analogue of phosphate and therefore disrupts several pivotal cellular              
events such as oxidative phosphorylation and ATP synthesis [11]. Arsenate reductase enzyme            
converts the As (V) to As (III) as a part of detoxification. The half-life of As is nearly 4 days,                    
but As (III) have a lower half-life compared to As (V) [12]. Generally, the bioavailability of                
iAs is 60% to 87% [13, 14], and the majority of iAs and its metabolites are excreted through                  
the urine and bile. iAs is easily absorbed by the gastrointestinal tract and after being               
metabolized in the liver and becomes methylated As. ​As interferes with several normal body              
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activities and affects the central nervous system, ​reproductive system, the hematopoietic           
system, ​cardiovascular ​system​, respiratory system, ophthalmic system and the gastrointestinal          
system (Figure 2, 3) [15, 16]. 
Arsenicosis causes a myriad of irreversible injuries in several organs in the prenatal period,              
early childhood and later in life and is considered as a carcinogen. The mechanisms by which                
As induces carcinogenesis include oxidative stress (OS), DNA damage and chromosomal           
abnormalities, altering of gene expression and epigenetic modifications ​[17, 18]. As affects            
the cellular function of several enzymes, particularly those involved in the heme synthesis             
and degradation [19]. As compounds have also been implicated in the inactivation of             
endothelial nitric oxide synthase (eNOS) via connecting with the thiol groups leading to an              
increase in reactive nitrogen species (RNS) which together with the reactive oxygen species             
(ROS) causes extensive lipid peroxidation (LPO) and apoptosis [20]. 
There is a growing interest in establishing a safe and effective treatment for iAs exposure.               
The use of plant and natural products for the remedy of human diseases is as old as the                  
humankind. The main advantages of medicines based on ​phytochemicals seem to be their             
high efficacy, little side effects and a low cost [21]. Curcumin (CUR), the yellowish and               
water-insoluble polyphenolic pigment extracted from the rhizome of ​Curcuma longa          
(Zingiberaceae), is well-known as a pleiotropic medicinal herb [22, 23]. However, there is             
little known about the protective effects of CUR against hazardous effects induced by the              
exposure to As, including those associated with damage to the nervous system, DNA, kidneys              
and liver. The purpose of this review is to summarize the scientific evidence concerning the               
organ toxicities induced by As, and the ameliorative role of CUR. 




As affects the regulation of several cellular signal transduction pathways (Figure 3). As                        
activate a series of downstream signaling cascades and disrupts various signaling pathways            
associated with cell growth, proliferation and apoptosis [24]. ​As can damage DNA and             
triggers the cell arrest at G or G/M phase [25, 26]. Arsenic trioxide (As2O3) can attenuate the                 
steady-state levels of CDK/cyclin complexes, such as CDK2, CDK6, cyclins A, D1 and E, in               
different tumor cells [27, 28]. ​As2O3 arrests the cell cycle by the suppression of              
cdc2-associated kinase and CDK2/6-associated kinases in compliance with the decreament of           
cdc25B/C phosphatases and the Rb protein hypophosphorylation, respectively [27, 28]. It has            
been found that p53 signaling pathway have a important role in As-created cell cycle arrest               
[29]. 
As exposure can induce apoptosis through disturbance of signal transduction, activation of            
activator protein-1 (AP-1), deactivation of constitutive nuclear factor-kappa B (NF-κB) and           
by inhibition of PI3K/Akt signaling. As causes imbalances in intracellular          
oxidation/reduction reactions which induce signaling axis that modulate early response genes.           
Transcription factors (TFs) related to stress response, i.e. AP-1 and NF-κB mediate the             
transcription of multiple downstream target genes [30]. Since upstream proteins which           
regulate AP-1, NF-κB, and nuclear factor (erythroid-2 related) factor 2 (Nrf2​) and nitric             
oxide synthase (NOS) all have reactive thiols, their oxidative modification through ROS,            
produced during As exposure, maybe the crucial step in various cellular responses and             
toxicity [31]. ​As stimulate ROS generation, a mitochondrial OS, which in turn            
decreases the matrix metalloproteinases (MMPs). The disrupted MMP increases the          




Mitogen-activated protein kinases (MAPKs) consist of a family of regulatory serine/threonine                  
phosphorylating proteins which regulate the signal transductions against different                 
extracellular stimuli and mediate the regulation of gene amplification, mitosis, motility,                   
metabolism, and apoptosis [33]​. ​The MAPK family encompasses important members such as             
extracellular signal-regulated kinases (ERKs), c-Jun amino-terminal kinase 3(JNK) and p38          
[33]. ​ERKs transduce the signaling which causes cell differentiation, proliferation and                    
transformation, whereas JNKs and p38 kinase react to stressful events, which leads to the cell                             
cycle arrest and cell apoptosis ​[34]​. ​As has an impact on various biological pathways since it                      
can induce proteins such as ERK2, p38 and JNK [35-37]. Thereore, the Ras-MAPK/ERK             
pathway seems to be sensitive to As damage [38]. 
Many family members of receptor tyrosine kinase (RTK), have emerged as a main regulators              
of important cellular processes, like cell proliferation, differentiation, metabolism, survival,          
propagation, and cell-cycle control [39]. Exposure of the cells to As promoted total cellular              
tyrosine phosphorylation possibly through direct interact with EGFR molecules to induce the            
conformational changes or the dimerization of EGFR, and eventually EGFR activation [40].            
As might activate EGFR via the production of ROS which stimulated the conformational             
altrations in the receptor [41]​. As exposure also produces dose-dependent toxicity through            
stimulation of epidermal growth factor receptor (EGFR) pathway intermediates, cSrc, Rac1,           
Shc, Grb2, MAPK or ERK kinases (MEK)1/2 and ERK1/2 [42, 43]. ​As-mediated            
ERK1/2 induction reversely regulates DNA polymerase beta expression and over-expresses          
heme oxygenase 1 (HO-1) at toxic concentrations [42]. ​As also can induce carcinogenesis             
and can promote tumor growth [44]. ​Generally, the ERK1​⁄​2 cascade is activated by             
mitogens like growth factors. Aberrant regulation of the ERK1​⁄​2 cascade can cause            
susceptible cells to undergo tumorigenesis ​[42]​. As induces tumorigenesis also through           
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the abrogation of p53 pathway causing uncontrolled proliferation [24]. ​Evidence also           
suggests a connection between As exposure and inhibited acetylcholinesterase (AChE)          
activity [45], generation of acetylcholine (ACh) and action of choline acetyltransferase [46]. 
The protein kinase C (PKC) family includes different isoenzymes with identical structures;            
all of which regulate various cellular actions. Three known PKC forms (PKCα, PKCε, and              
PKCδ) were found to mediate As-induced cellular signal transduction resulting in AP-1            
induction [47]. As induced translocation of PKC isoforms from the cytosol to membranes,             
where these isoenzymes mediate As-induced AP-1 activation via various MAPK (ERKs,           
JNKs, and p38) pathways [47].  
Autophagy flux disturbance has also been observed in As models. Sodium arsenite (NaAsO2)             
causes to an accumulation of LC3-II and p62 proteins in female mice. The LC3-II is an                
crucial protein for elongation and fold of the phagophore in the autophagosome membranes.             
Whereas, p62 is a receptor protein, which binds to the specific cargo, eventually leads to the                
cargo’s degradation whitin autophagolysosomes [48, 49]. ​The This phenomenon is          
related with ERK overinduction, via SOCS3-dependent IL-6​/​STAT3 signaling        
cascade inhibition [50]​. 
Angiotensin II Type I receptor (AT​1​R) as a G protein-coupled receptor coordinate most of the               
physiological or pathological roles of AngII as a part of renin–angiotensin system [51, 52].              
NaAsO2 increases the expression of AT​1​R by ROS-mediated induction of the JNK pathway.             
Long-time As exposure can enhance the pathogenic roles of AngII via modulating a deviant              
AT​1​R signaling pathway, resulting in hypertension [53].  
2. Receptor pharmacology 
As can disrupt the hormone-induced gene expression mediated via the glucocorticoid           
receptor (GR) [54]. ​Glucocorticoids activate a different biological process that is mediated            
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via their connection with the cytosolic steroid hormone receptor GR. GR coordinates various             
metabolic and homeostatic functions in almost all tissues [55]. It has been shown that              
non-toxic concentrations of As can interact directly with GR complexes and specifically            
inhibit GR-mediated transcription [56]. 
It has been shown that As can cause male infertility by suppression of ​androgen                       
receptor (AR) transcriptional activity via inhibiting the recruitment of AR to promoters of its              
target gene [57]​. ​As have also been found to be an active endocrine disruptor of               
estrogen receptor (ER)​-mediated gene expression, both ​in vivo​ and ​in vitro​ [58]. 
As can also interrupt the function of the hypothalamic-pituitary-adrenal (HPA) axis.           
As increases serum corticosterone concentrations, decreases levels of corticotropin-releasing         
factor receptor 1 in offspring hippocampus, and raises dorsal hippocampal serotonin           
5-hydroxytryptamine receptor as well as receptor-effector coupling [59]. It has been reported            
that As (III) affects thyroid hormone levels and interrupts thyroid function via alterings the              
expression of TR-associated genes. As exposure change the expression of thyroid hormone            
receptor (TR) response element as well as the endogenous TR-regulated type I deiodinase             
gene [60].  
The transient receptor potential melastatin 4 (TRPM4) is a voltage dependent non-selective            
cation channel [61]. TRPM4 is mainly found in the heart, and CNS, as well as its expression                 
also found in endothelial cells (ECs) from various vascular tissues [62]. As2O3 over-express             
the both transcription and translationsl levels of TRPM4 through entering the cell membrane,             
TRPM4 channels is over-activated in endothelial cells (ECs). The activated TRPM4 channels            
causes to unlimited Na​+ influx which leads cell membranes depolarization and Ca​2+ overload,             




As can substitute phosphate in various biochemical reactions due to their identical 
structure and characteristics [64]. For instance, arsenate interacts with glucose and gluconate            
[65] to generate glucose-6-arsenate and 6-arsenogluconate, respectively. These elements are          
similar to glucose-6-phosphate (G6P) and 6-phosphogluconate, respectively. During the         
glycolysis, glucose-6-arsenate is a substrate for glucose-6-phosphate dehydrogenase (G6PD)         
and can suppress hexokinase, as does G6P [66, 67]. 
The metabolomic investigations demonstrated that alteration in the metabolism of energy,           
amino acid, purine, choline as well as degradation of membrane phospholipids is implicated             
in the cell apoptosis in As-induced toxicity [68]. As enforces allosteric inhibition of pyruvate              
dehydrogenase complex which catalyze the oxidative decarboxylation of pyruvate to          
synthesis acetyl-COA via NAD+. Therefore, the cellular energy system is disrupted and            
results in apoptosis [12]. ​The As toxicity could be via its interaction with sulfhydryl groups               
related to proteins and enzymes and via boost of the ROS in the cells leading to cell damage                  
[69]. ​In addition, As activate unstable mitochondrial metabolism, reduced withdrawal          
of ROS, attenuate protein production and changing membrane lipid polarity and           
fluidness resulting in the mitochondrial ​oxidative injury [70].  
Furthermore, As can also lead to thiamine deficiency through mitigating its availability and             
also cause lactic acidosis via increasing the amount of lactic acid ​[12]. NaAsO2 increased               
LPO, DNA fragmentation, triacylglycerides, total cholesterol and low-density               
lipoprotein cholesterol (LDL-C), while antioxidant status and high-density               
lipoprotein cholesterol (HDL-C) were found to be decreased [71]. 
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As regulate the expression of the heat shock proteins (Hsps) families. Hsp are regulated via a                
complex regulatory mechanism, which needs the integration of most signal pathways. This            
stress response is an adaptive phenomenon in organisms [72]. For instance, Hsp90 is             
involved in the regulation of cellular redox status. Redox-regulated communications between           
cytochrome c and cytoplasmic Hsp90 are implicated in apoptosis. These interplays can be             
inhibited by high doses of NaAsO2 in a purified system [73]. 
4. Immunity 
As has been shown to lead immunotoxicity, skin lesions and suseptibility to developing             
malignancy (Figure 3)[74, 75]. In difernent experimental model, As exposing has been found             
to attenuate IgM/IgG antibody-forming cell response [76, 77] as well as repress delayed type              
of hypersensitivity response to phytohemagglutinin ​[78]​. NaAsO2 can change immune cell           
populations causing to functional altrations in immune response particularly decreament of           
cutaneous contact hypersensitivity response [79]​. 
Immunosuppressive features of As lead to inability of innate immune system to            
eradicate various bacterial and viral infection such as HIV-1 [80] and influenza A             
(H1N1) infection[81]. In Bangladesh, people who expose to As, more vulnerable to            
lower respiratory tract infections and diarrhea [82-84]​. ​Neutrophil and macrophages          
as a main regulator of innate immunity have been reported to be a major cellular               
target population of As toxicity​[85, 86]. For instance, As prompts apoptotic cell death in              
neutrophils and change phenotype of Macrophages. Remarkable loss of cell adhesion           
capability, ​reduce NO generation, and reduce ​chemotactic​/​phagocytic dysfunction and         
reduced regulation of CD54/F-actin with these immune cells [87-89]​. ​iAs inhibits the            
differentiation of monocytes to functionally active macrophages through suppressing survival          
signaling pathways [90]. Additionally, As can alters the phenotypic and genotypic properties            
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of mature macrophages [87, 91, 92]. iAs significantly changes the expression of a large              
number of correspounding genes particuarly activated or inhibited whitin the differentiation           
process, possibly via an oxidative stress-associated mechanism [91, 92]. ​Indeed, As also            
mitigate cystic fi​brosis transmembrane conductance regulator (CFTR)-mediated       
chloride secretion; so abolished clearance of respiratory pathogens [93].  
There are remarkable negative correlation between ​long-time As exposure and the number and                         
action of T regulatory cells in adults [94]. It has been shown that maternal As exposure ​during                                 
pregnancy ​was related with a reduction in the frequency of pan T cells in the placenta in spite of                                    
increased inflmmatory cytokines amounts, as well as reduced ​thymic size and function in infants                      
and elevated morbidity from infectious diseases[84, 95, 96]. 
iAs can also markedly alter development, induction and proliferation of T cells [97].             
Actually, iAs-dependent suppression of peripheral T cell proliferation is mainly related with            
inhibition of interleukin-2 (IL-2) secretion which is necessary cytokine for induction of T             
cells and their progression to the cell cycle [98]. ​As2O3 enormously impaires the releasing of               
IL-12 and IL-23 from activated dendritic cells and reduce the activation of T helper (Th) cells                
[99, 100]. Altogether, these evidences indicated that As may change both the action and the               
number of T cells, which are of important for cell-mediated immunity [90, 101].  
3. Curcumin 
Curcumin [1,7-bis(4-hydroxy-3-methoxy phenol)-1,6-heptadiene-3,5-dione], is an alkaloid      
and the active component of turmeric and ginger [102]. Since at least 2500 years ago,               
turmeric root has been extensively used to add color and flavor in cooking and as a remedy in                  
traditional medicine. CUR showed various biological advantageous such as anti-microbial,          
antioxidant, lipid-lowering, hypoglycemic, anti-inflammatory and anti-ageing properties       
[103-108]. Molecular targets of CUR are numerous including transcription factors,          
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transporters, enzymes, microRNAs, pro-inflammatory cytokines, apoptotic proteins, growth        
factors, hormones and receptors [109-113].  
CUR as a chain-breaking antioxidant which gives H from the phenolic moiety [114]. The              
aromatic ring systems (phenols) are linked via 2 α,β-unsaturated carbonyl groups.           
Furthermore, CUR can inhibit LPO and quenching hydroxyl and superoxide radicals through            
the phenolic OH group and the CH2 group of the β-diketone section [115, 116]. Multiple               
molecular targets in different cell types, i.e. NF-kB, P38, hypoxia-inducible factor (HIF-1α),            
peroxisome proliferator-activated receptor-γ (PPARγ) and AKT, are involved in the          
anti-inflammatory effect of CUR [117, 118].  
In another pathway, CUR exerts anti-oxidative functions through activation of antioxidant           
responses via Nrf2 activation and effectively suppresses a host of factors which contributes to              
inflammation [119]. CUR can decrease the expression of genes implicated in apoptosis,            
proliferation, and transformation [120].  
CUR reduces N-nitrosodiethylamine (DEN)-caused hepatotoxicity by modulating the        
enzymes involved in the oxidant stress, liver function, lactate dehydrogenase A (LDHA),            
alpha-fetoprotein (AFP) and the cyclooxygenase (COX)-2/Prostaglandin E2 (PGE2) cascade         
[121]. CUR has been shown to have ameliorative effects in the As-induced genotoxicity [122,              
123], nephrotoxicity [124], hepatotoxicity [125], angiogenesis [123], dermatological        
disorders [126], reproductive intoxication [127], neurotoxicity [128] and immunotoxicity         
(Figure 4) [129]. ​It has been reported that CUR also can used as a co-treatment with ​chelating                 
agents in a synergistic way​ ​for the treatment of As intoxication[130]​. 




  Acute tubular necrosis with acute renal failure has been observed in patients with acute As               
poisoning. Some of these cases can progress to cortical necrosis and ultimately chronic             
kidney disease. The kidney injury can be due to the hypotensive shock, direct impacts of As                
on tubule cells resulting in tubular damage and hemoglobinuria or myoglobinuria which can             
lead to proteinuria. Acute tubulointerstitial nephritis has also been considered as a clinical             
presentation of acute As intoxication [131]​. 
NaAsO2 causes shrinkage of the glomerulus, disturbed glomerular integrity, and a reduction            
in the glomerular area as well as an increase in the Bowman's space ​due to the of glomerular                  
atrophy. Collagen is the important protein ingredient of glomerular basement membrane and            
is necessary for glomerular integrity [132]. As affects cell antioxidant defense system to             
activate LPO and the disturbance of cell polyunsaturated fatty acid. As also suppress protein              
synthesis [133]. ​Simultaneous treatment with CUR plus NaAsO2 ameliorated the side effects            
of As on the glomerulus and proximal tubule, ​glomerular area, serum total antioxidant             
capacity and the circulating levels of malondialdehyde (MDA) ​[134]. It has been shown that              
CUR reduced the As-induced increase in bilirubin, urea and creatinine (Cr) in an             
experimental model of As toxicity [46, 135, 136]. ​The elevated amount of serum Cr after               
As2O3 exposure is because of the increased formation of metabolic waste product related to              
metabolism of musclse. Moreover, Cr is anhydride of creatine. Muscle consists           
phosphocreatine which endores involuntary cyclization with miss of inorganic phosphorous          
to constitute creatine. Transformation of creatine into Cr is a non-enzymatic immutable            
procedure. Since, affinity for thiol group of different proteins exist in the cell membrane of               
muscles, As harms the cells due to which the enzyme, creatine phosphokinase, released from              
the cells which is acounted for the transformation of phosphocreatine in to creatine. Therefore              
enhances the value of Cr [137]. ​Ameliorative role of CUR against As induced pathologies              
could be due to the antioxidant potency of this natural agent. The protective roles of ​Curcuma                
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aromatica ​leaf extract were shown on the nephrotoxicity of As2O3 in the albino rats. As2O3              
poisoning significantly increased the serum level of uric acid, blood urea nitrogen, and Cr              
because of renal dysfunction. ​Curcuma aromatica (50 mg/kg BW) normalized the serum            
levels of uric acid, blood urea nitrogen and Cr [137]. ​Curcuma aromatica inhibits tubular              
necrosis and back-leak of filtrate as well as normalize serum urea consentration by             
antioxidant features [137]. 
OS is a hallmark of As-induced liver, renal and neuronal injury [138]. As is not a redox                 
metal, however, is a potent disruptor of the cell signaling pathways through inducing reactive              
oxygen and nitrogen radical production, where superoxide anion radical is the main species             
that is turned to hydrogen peroxide and finally to hydroxyl radical [139]. Hydroxyl radical              
can interact with macromolecules resulting in OS, LPO, DNA damage and extensive changes             
in the cellular regulatory mechanisms [139-141]. 
Several enzymatic antioxidants such as superoxide dismutase (SOD), catalase (Cat),          
glutathione peroxidase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST)        
and G6PD are the first line of intracellular defence against OS induced by As exposure [142].                
SOD and Cat are considered to be the two preliminary subcellular defence of antioxidant              
system against free radical production with As exposure. SOD catalysis the conversion of             
superoxide anion to hydrogen peroxide (H2O2), whereas Cat or GPx converts H​2​O​2 to a              
water molecule. Glutathione (GSH) associated enzymes such as GPx and GR acts directly or              
indirectly against oxidation, but GST is also involved in the metabolic detoxification​. GSTs             
maintain a shield against As via conjugation or decrement with GSH as well as relief the OS                 
and subsequent LPO induced by As [143]. ​GST and GPx decrease the organic             
hydroperoxides in the membranes and lipoproteins accompanied by GSH. GSH as a            
tripeptide non-enzymatic antioxidant has a crucial role in the free radical quenching and acts              
as a co-factor for numerous enzymes participating in the general antioxidant defence [144]. ​In              
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addition, GSH inhibits the oxidation of SH-groups [145]. Hence, these antioxidant enzymes            
reduce the deleterious effects of ROS​. 
The protective role of CUR against As could be through free radical scavenging, which              
would inhibit the oxidation of SH-group (Figure 4) [146]. ​The renoprotective effect of CUR              
is due to the scavenging of ROS and inhibition of hydrogen peroxide-induced oxidative             
injury in a renal cells [147]. Furthermore, CUR can potentially inhibit the thiol depletion and               
improves the renal GSH amount [136]. ​Thiols (SH-group) considered to be a main protector              
of cells against ROS. Furtheremore, thiols as a target site for As-induced cellular injuary can               
remarkably decrease SH-group content​. ​CUR enhances the activities of antioxidant enzymes           
(SOD, Cat, GSH, GR, GPx, and GST). Simultaneous administration of NaAsO2 with CUR             
decreased the levels of thiobarbituric acid-reactive substances (TBARS), whereas augmented          
the actions of the antioxidant enzymes, and the amount of SH-groups [148].  
Sankar ​et al​. reported that As exposure through drinking water (25 ppm; 42 days) led to OS                 
and tissue injury in kidneys of rats. However, nanoparticle-encapsulated CUR (NP-CUR)           
treatment remarkably increased the GSH level (60%), GR function (67%) in kidneys as well              
as reduced the LPO in the rats exposed to As [135]. 
4.2.DNA damage 
As is categorized as a group 1 human carcinogen as per the epidemiological surveys [15]. It                
has been shown that As have genotoxic effects such as induction of OS, enhancing the               
number of micronucleus (MN) and chromosomal aberrations, DNA strand break, cross-links           
between DNA and protein, reduction of proliferation index, suppression of DNA repair along             
with production of 8-hydroxy-20-deoxyguanosine (8-OHdG) as an indicator of OS to DNA            
caused by As [149-151]. The ROS-related DNA damage 8-oxoguanine is removed through            
8-oxoguanine DNA glycosylase, which encodes through ​OGG1 gene. It has been shown that             
OGG1 gene expression is significantly associated with chronic exposure to As [152]. As             
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prevents the enzymes contributed in repair, so causing to the change of DNA replication and               
repair mechanisms. ​Suppression of DNA is because of the inihibitory effect of As (III) on               
DNA ligase II/I [153]. As (III) can produce NO to damage DNA, which thus induce               
ADP-ribosylation [153].  
CUR has a protective effect against the As-induced DNA lesions through combating ROS             
production and LPO, promotion the activities of numerous antioxidant enzymes, i.e. Cat,            
SOD, GPx, GR, GST and GSH [122]. CUR also induces over-expression of the polymerase,              
an enzyme responsible for DNA repair [153].  
In another study, CUR effectively restored the genotoxic effect of As by decreasing the              
number of structural aberrations and hypoploidy (Figure 4) [154]. CUR also suppressed the             
8-OHdG and ​OGG1 regulation and activated the DNA repair enzymes in the repair pathways              
at the protein and gene levels [155]. The protective effects of CUR against As-induced              
genotoxicity may be due to its antioxidant and free radical scavenger properties [156]. CUR              
can trap the free radicals and induce O6-methylguanine-DNA methyltransferase (MGMT)​, a           
protective genome protein [157, 158], and HO-1 activity which donates H from phenolic OH              
group and suppresses the iNOS induction resulting in protection of DNA [159]. Biswas ​et a.l.               
reported that treatment of Swiss albino mice with CUR prevented the NaAsO2-induced DNA             
lesions through decreasing the comet tail moment of whole blood and MN population in the               
cultured splenic lymphocytes [160]. Findings of in vitro ​and the field trials among Indian              
populations exposed to chronic groundwater As demonstrated that NaAsO2 can induce DNA            
damage and generates ROS which was efficiently ameliorated by CUR [161].  
4.3. Neurotoxicity 
Metals can cross the blood-brain barrier (BBB) and deposit in the brain resulting in              
neurobehavioral disorders [162]. Deposition of As in the central nervous system impairs the             
neuronal activities, reduces the neuronal migration, prevents the neural progenitor cells           
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proliferation and maturation together with altered dopaminergic, cholinergic, serotonergic         
and glutamatergic systems functions [162-164]. ​Children who are chronically exposed to As            
have difficulties in cognitive development and verbal intelligence [165, 166]. As           
related-neurotoxicity occurs by the promotion of apoptosis via activating p38          
mitogen-activated protein kinase and JNK3 pathways along with activation of caspase-9, an            
initiator of apoptosis [167]. ​Degenerative lesions and vascular engorgement was found in            
brain tissues demonstrate the possible of the As to enforce neurotoxicty. As-induced            
production of free radicals and following OS is one of the main mechanisms which mediate               
conversion in these tissues [168]. Although, brain is more sensitive to As due to that has an                 
inefficient oxidative system [169]. Additionally, brain possess a high levels of           
polyunsaturated fatty acid [170]. 
CUR can inverse neuroleptic-created tardive dyskinesia in rats [171]. CUR also exhibited            
significant neuroprotection in focal cerebral ischemia via suppressoing of LPO and regulating            
antioxidant enzymes [172]. It was also reported to be has potential in decreasing the              
peroxynitrite generation in cerebral ischemia [173]. ​A decrease in As amounts in brain             
tissues, CUR [174] that may have possibly reduced the load of As. 
Accumulating evidence suggests that As-induced neurotoxicity is neutralized by CUR          
through modulating the OS and dopaminergic functions. NaAsO2 (20 mg/kg BW) reduce the             
levels of dopamine (28, 51 and 35%), norepinephrine (54, 22 and 35%), epinephrine (46, 47               
and 29%), serotonin (44, 25 and 54%), 3,4 dihydroxyphenylacetic acid (20, 34 and 37%) and               
homovanillic acid (31, 41 and 46%) in the corpus striatum, frontal cortex and hippocampus,              
respectively. CUR can modulates the levels of NO and brain biogenic amines in             
As-contaminated rats [128].  
NaAsO2 (20 mg/kg BW) and CUR (100 mg/kg BW) therapy led to an increased locomotor               
function and grip force as well as promoted the rota-rod task in As treated rats. A remarkable                 
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improvement in behavioral, neurochemical and immunohistochemical indices in the rats          
which concurrent received As and CUR demonstrates the neuroprotective potential of CUR            
[163]. ​CUR potentially crosses the BBB and reduce senile plaques and cerebrovascular            
amyloid angiopathy as well as decreases amyloid accumulation and neuroleptic-created          
tardive dyskinesia [171, 175]. ​Jahan-Abad and coworkers provided evidence on the           
preventive effect of CUR combating the toxic effects of As on the viability, telomerase              
activity and cell death of neural stem cells [176]. ​CUR effect on elevating telomerase activity               
might be mediated via upgrading the stability of telomerase structure and successively            
enhancing the halflife of the enzyme [177]. Cell damage/death in As-treated neural stem cells              
happen via caspase-dependent apoptosis and CUR attenuated caspase processing[176]. ​As          
can also induce white matter lesions and damage the brain hippocampal CA1 area.             
Co-treatment with antioxidants (N-acetylcysteine and CUR) reverse these changes and          
protect cells against inflammation through decreasing the levels of MMP-2, -9 and TNF-α             
inflammatory factors[178]. 
It has been shown that As can disturb the maturity of the pre- and post-synaptic signaling                
proteins related to the dopaminergic axis in the corpus striatum. ​The concurrent exposure to              
CUR led to the amelioration of the As-induced changes in the regulation of DAD2 receptors,               
pPP1α, PKA, pCREB and pDARPP32. Moreover, modulation in the regulation of pGSK3β            
and BDNF in the corpus striatum via CUR demonstrates the significance of the neuronal              
survival cascade in As-stimulated dopaminergic dysfunction [179]​. ​In similar in vivo and in             
vitro experiment, administration of CUR alleviated the NaAsO2-induced variances in the           
levels of N-methyl-D-aspartate (NMDA) receptors and its subunits along with synaptic           
proteins (pCaMKIIa, PSD-95 and SynGAP). CUR also compensated for the          
NaAsO2-induced reduction the levels of pAkt, pGSK3β, pERK1/2, BDNF and pCREB.           
Interestingly, CUR exerts its neuroprotective effects against NaAsO2 in the hippocampus via            
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regulating PI3K/Akt/GSK3β pathway [180]. ​As-induced decreament in brain        
acetylcholinesterase action were also observed to be mitigated after CUR treatment in rats             
[46]. 
NaAsO2 (5 mg/kg BW) remarkably mitigated the function of the brain and plasma AChE              
and levels of plasma total protein, albumin and HDL-C, while increased the levels of urea,               
Cr, bilirubin, cholesterol, total lipid, LDL-C, triglyceride and glucose which were reversed by             
the administration of CUR (15 mg/kg BW) in rats [46]. 
4.3.1. Cholinergic dysfunctions 
As exposure possibly lead to cholinergic dysfunctions linked with the activity of the brain              
AChE and disturbed learning and memory in experimental models [181, 182]. ​It has been              
reported that iAs has major e​ff​ects on brain primary cultures obtained from transgenic             
Tg2576 mice, which increased the expression of amyloid precursor protein (APP)           
and are associated to the early development of Alzheimer​’​s disease (AD)[183].           
Chronic As exposing induces the JNK3 and p38 MAPK related with the construction of              
neurotic plaques (NFs) and neurofibrillary tangles(NFTs) [184] which are associated with the            
AD [185]. It has been shown that CUR can reverse As-induced brain cholinergic deficits              
[186]. ​CUR decreased the vasoactive peptide endothelin1-created cell death of hippocampal           
neurons through diminishing of cleaved caspase-3, decreament the activity of caspases 3/7            
via inhibiting the elevation in c-Jun amounts [187]. 
Concurrent supplementation of rats with NaAsO2 (20 mg/kg BW) and CUR (100 mg/kg BW)              
enhanced the learning and memory execution related with the over binding of            
[3H]quinuclidinyl benzylate ([3H]-QNB) and the activity of AChE in the hippocampus and            
frontal cortex versus the As group. An increase in the transcription, translation and             
immunoreactivity of choline acetyltransferase, an index of cholinergic neurons, as well as            
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binding of cholinergic–muscarinic receptors (MAChR), Nissl-stained hippocampus was also         
observed in the As+CUR than As group [186]. 
Similarly, treatment with both As (20 mg/kg BW) and CUR (100 mg/kg BW) protected              
against the alterations in the mitochondrial membrane integrity, function of mitochondrial           
complexes and a reduction in the CHRM2 receptor gene in specific brain regions of rats               
along with regulating the amplification of brain pro- and anti-apoptotic proteins which are             
induced by As [188].  
4.4.Hepatotoxicity 
The liver is the most common site for the metabolism and methylation of As [189]. The As                 
methylated metabolites produced in the hepatocytes, methylarsinic acid (MMA) and          
dimethylarsinic acid (DMA), are primarily excreted through urine as a detoxification and            
elimination system (Figure 2, 3) [190]. Furthermore, the liver is also considered as one of the                
main targets of As toxicity. Histopathological changes in the liver tissue, abnormal liver             
function tests with gastrointestinal manifestations and an increase in serum enzymes are            
frequent during acute and chronic arsenicosis [191, 192]. ​It has been shown As intoxication              
remarkably discharge delta-aminolevulinic acid dehydratase (ALAD) activity in liver tissues          
of mice [193]. It has been suggested that the leakage of enzymes due to the liver damage is                  
prohibited through the liver cell membrane stabilizing activity of CUR. It has been shown              
that CUR potentially can enhance the As methylation and excretion through urine [125]. Due              
to its polyphenolic structure and β-diketone functional group, CUR has powerful antioxidant            
potencies compared to other flavonoids with only one phenolic hydroxyl group [194].  
As2O3 administration causes the production of reactive ROS, As accumulation, and           
attenuation of various antioxidant enzymes in the liver of adult male Wistar rats. CUR              
administration (15 mg/kg BW) had hepatoprotective effects from the As induced-worsening           
of antioxidant levels and OS. CUR also led to a remarkable reduction in the hepatic As                
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accumulation and serum marker enzymes including aspartate transaminase (AST), alanine          
transaminase (ALT) and ALP [195]. CUR administration also (0.4 mg/kg BW) significantly            
reduced the intracellular ROS generation via promoting the activity of GR and ROS             
scavenging enzymes (GST, GPx, SOD and Cat) in the hepatic tissue of adult male Swiss               
Albino Mice exposed to As2O3 [127]. ​Similarly, As-induced elevation of serum ALT and             
AST, hepatic MDA, as well as the decrements of serum and hepatic GSH concentrations              
were all also reversed by administration of CUR[125]. 
In another study, for enhancing the bioavailability of CUR, encapsulated CUR in chitosan             
nanoparticles (ECNPs) have been shown to have a superior antagonistic effect against            
As-induced toxicity than free CUR. Co-treatment with CUR or ECNPs with As significantly             
ameliorated the alterations in the hepatic OS markers. As exposure led to ROS generation and               
an increase in LPO, which was significantly reduced after CUR administration [196]. Sankar             
et al. studied the efficacy of the NP-CUR from NaAsO2-related hepatic oxidative injuries in              
rats. Hepatotoxicity of As was manifested by an elevation of the serum ALT and AST               
activities and led to related histological changes in the liver. As elevated LPO and reduced               
the activities of SOD, Cat, GPx and GR in the liver. CUR administration resulted in a                
significant improvement of the As-induced effects and to a greater extent by CUR-NP. These              
findings imply that when CUR given in a nano-encapsulated form has better efficacy on As               
related toxicities compared to free CUR[197]. 
CUR reduced the toxic biochemical responses of As through lowering the acid             
phosphatase activity (43-70%), alkaline phosphatase (ALP) activity (40-63%) and GSH          
activity (27-41%) as these enzymes are markers for As-induced toxicity ​in Swiss Albino             
Mice [198].  
Recently, CUR has been suggested to have chemopreventive effects via the induction of             
Nrf2. NF-E2 related factors (Nrfs) are a group of transcription factors which modulate the              
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cellular stress response to OS via the ​cis​-acting antioxidant response element (ARE). Usually,             
ARE-dependent genes are responsible for mediating the redox homeostasis of cells and            
inhibit oxidative injury. Under OS, Nrf2 and/or Nrf1 bind and activates the expression of              
detoxifying genes [199]; NAD(P)H:quinone oxidoreductase 1 (​NQO1​), ​GSTs​,        
Gama-glutamylcysteine synthetase heavy subunit (​γ-GCS​h​) and light subunit, HO-1,         
glutamate-cysteine ligase catalytic (​GCLC​) and regulatory (​GCLM​) subunits, and         
peroxiredoxin 1 [200]. 
It has been shown that the effects of CUR against the As-induced hepatic damages are               
potentially mediated through activation of the Nrf2 pathway. Post CUR administration, both            
the hepatic Nrf2 protein and two primary Nrf2 downstream genes including NADP(H)            
quinine oxidoreductase 1 (NQO1) and HO-1, were over-expressed. Considering the potent           
antioxidative and detoxifying capacities of HO-1 and NQO1, their up-regulation may, in turn,             
reduce the As-induced OS [125].  
NaAsO2 reduces the cell viability and induction of apoptosis via an increase in the number of                
cells with ROS generation, loss of mitochondrial transmembrane integrity, changing the           
function of cytochrome c oxidase and citrate synthase, increasing the cell population with             
sub-G1 DNA content and DNA fragmentation in murine splenocytes. Co-treatment of CUR            
with NaAsO2 resulted in a significant improvement in cell viability and attenuation of the As               
induced apoptosis-associated molecular alterations [201].  
Tetrahydrocurcumin (THC), one of the main metabolites of CUR, in certain biosystems, was             
shown to have a higher antioxidant function compared to CUR. Muthumani and co-workers             
administrated As (5 mg/kg BW) with THC (80 mg/kg BW) for 28 days in a rat model. As                  
treatment-induced hepatotoxicity as evidenced by elevated activities of serum AST, ALT,           
ALP and bilirubin as well as worsened the lipid peroxidative parameters, TBARS. As also              
worsened serum lipid levels, reduced the antioxidant activities of SOD, Cat, GPx and GSH              
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along with mitochondrial enlargement, suppression of cytochrome c oxidase, Ca2+ATPase          
and a diminution of mitochondrial calcium accumulation. Pre-treatment with THC          
significantly mitigated the toxic effects of As in the rat liver as well as scavenged the                
As-related free radicals [202]. Supporting those findings, long time exposure to NaAso2            
resulted in increased in the levels of AST, ALT, ALP and lactate dehydrogenase (LDH),              
decreased activities of membrane-bound ATPases, enzymatic antioxidants including SOD,         
Cat, GPx, GST, GR and G6PD along with non-enzymatic antioxidants like reduced GSH,             
total SH-groups, vitamins C and E. ​Administration of THC showed a significant inhibition of              
As-induced hepatotoxicity [203]. Accumulating evidence shows that As can trigger ROS           
such as singlet oxygen, superoxide anion, hydrogen peroxide, hydroxyl radical, and peroxyl            
radicals [204]. 
The ​HER-2 gene is a putative oncoprotein which is up-regulated in many types of human               
tumors. Interestingly, ​it has been reported that As ​could induce the over-expression of HER-2              
and other oncoproteins; and CUR, as a chemopreventive and therapeutic agent has the             
inhibitory activity on HER-2-overexpressed hepatocellular carcinoma. Based on these results,          
it could be proposed that CUR has the potential to be developed as a complementary               
anti-cancer agent to treat hepatocellular carcinoma. Besides, CUR can protect hepatic cells            
from As-toxicity damage [205]. 
4.5.Dermal disorders 
iAs exposure increases the susceptibility to different dermal pathologies such as           
hyperkeratosis and skin tumor. Immunohistochemical evidence indicated that the appearance          
of 8-oxo-deoxyguanosine(8-oxodG) in keratosis and healthy tissues of As induced skin           
malignancies [206].  
CUR can lead to Nrf2 activation, Nrf2 protein nuclear accumulation and over-expression of             
ARE-target genes in the HaCaT keratinocytes. CUR at high doses also enhanced the             
23 
 
translation of the Nrf2. Administration of low doses of CUR increased the viability of HaCaT               
cells from the iAs-intoxication and also mitigated the Asi-induced transcription of cleaved            
caspase-3 and PARP. On the other hand, the expression of Nrf2 is under the control of                
Kelch-like ECH-associated protein 1 (KEAP1) via ubiquitination and proteasomal         
degradation. Interestingly, the transcription of KEAP1 ​was also increased by CUR, indicating            
possible feedback from Nrf2 to KEAP1. Notably, KEAP1 ​knockdown remarkably weakened           
the cytoprotection of CUR [126]. It may be since NRF2 was already fully activated owning to                
the absence of ​KEAP1​, and thus maximum protection against iAs was already in place, as               
pointed via the significant right-ward shift ​of the response curve observed in the untreated               
cells. Thus, CUR treatment did not further activate NRF2 and hence, no further protection              
[126]. 
4.6.Other arsenic induced-pathologic conditions 
Chorionic exposure to As disturbs the action of several cellular immune components            
including leukocytes and macrophages thereby affects cellular immune responses resulting in           
immunosuppression [84, 207]. ​Different mechanisms for the effect of As on the immunity             
have been proposed. Apoptosis has been found as an major mechanism of As-induced             
immunosuppression in human [208]. A study on peripheral blood mononuclear cells of cases             
which drinking water with low/moderate As levels revealed modulations in expression of T             
cell receptor (TCR), T cell cycle regulation, and apoptosis [209]. Anemia and leucopenia are              
among the most common effects of toxicity from acute or chronic As exposure. It has been                
reported that the ​Haridra (turmeric root) attenuates the experimentally As-induced reduction           
of hemoglobin level, red blood cell count and white blood cell count in calves [210]. ​CUR                
can reverse the haematological alterations through restoration of enzymes related to haem            




It has been shown that CUR can protect against immune dysfunction due to the As exposure.                
Considering spleen weight as an indicator of splenic dysfunction, As reduced the splenic             
lymphocyte proliferation, delayed-type hypersensitivity response and secondary antibody        
response to a specific antigen which was reversed by CUR [129]. CUR has a protective effect                
against As-related apoptosis in the rat thymocytes through its free radical scavenging            
potential [211]. 
An excess of ROS can be implicated in several reproductive disorders such as polycystic              
ovary syndrome. Wang and colleagues established an animal model of the ovarian OS by              
injection of NaAsO2 to examine the inhibitory role of CUR against OS damage. CUR              
therapy significantly elevates SOD, whereas reducing the ROS and MDA in the ovary.             
Immunohistochemistry of the ovarian tissues demonstrated that the higher value of atretic            
follicles and the suppression of granular cells proliferation under OS would be abrogated via              
CUR treatment. In addition, the OS-induced p66Shc over-expression would be mitigated           
after CUR therapy. Altogether, these findings demonstrate that CUR can scavenge free            
radicals and provide the antioxidant circumstances in ovarian tissue upon modulating the            
expression of p66Shc [212]. ​NaAsO2 inhibited the actions of the uterine enzymatic            
antioxidants including SOD, Cat, and peroxidase. The circulating levels of vitamin B12 and             
folic acid were reduced followed by an elevated serum LDH, homocysteine level and hepatic              
metallothionein-1 in As-treated rats. Uterine tissue necrosis with the disturbance of ovarian            
steroidogenesis was manifested in As-administrated rats with an over-expression of uterine           
NF-κB and IL-6 as well as an increase in serum TNF-α levels. Oral supplementation of CUR                
(20 mg/kg BW/day) in As-treated rats reversed these abnormalities by detoxifying As. The             
underlying mechanism of As detoxification might be implicated in the stabilization of the             
S-adenosine methionine (SAM) pool by maintaining the circulating levels of vitamin B12,            
folate, and homocysteine [213].  
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NaAsO2 directly affects the antioxidant enzymes (SOD, Cat, GPx, and GST) and regulation             
of antioxidant genes (SOD1, Cat, and GPx1) in embryonic fibroblast cells and caused             
oxidative damage through increasing the cellular levels of hydrogen peroxide, hydroxyl           
radical and LPO. It has been found that CUR potentially improved antioxidant system genes              
and enzymes to defend the fibroblast cell toxicity created by NaAsO2 [214]. 
 
5. Conclusion and future prospective 
The gold standard treatment of As poisoning is by ‘chelation therapy’ though chelating drugs              
are limited by different side effects and reduced selectivity and specificity. ​Accumulating            
evidence supports that CUR administration is effective in combating As-mediated toxicity in            
Wistar rats and Swiss albino rats. However, most of the studies discussed does not              
demonstrate the capability of CUR in reducing the body burden of As nor any efficacy in                
humans with chronic arsenic poisoning. In addition, no placebo-controlled trials with this            
natural agent have been performed nor the efficacy of their long-term use has been assessed.               
The benefits of CUR at the cellular level should be validated in human subjects with chronic                
As toxicity. The beneficial effects of CUR should be assessed in arsenecosis through             
endpoint evaluations such as ​changes in the As concentrations in blood, nail and faeces,              
changes in urine As metabolites, size of keratotic lesion or scoring of palmar arsenical              
keratosis. ​Suggested markers for evaluation of the effect of CUR in As-associated kidney              
damage among arsenicosis patients are expression levels of kidney injury molecule (KIM)            
and changes in the activities of enzymes-related with carbohydrate metabolism such as            
hexokinase, LDH, G6PD and malate dehydrogenase. Additionally, It was observed that As             
disrupts the normal levels of metabolic enzymes in the body which are robust biomarkers              




It has been suggested that co-treatment with CUR and arsenate chelator may offer             
advantageous effects in a synergistic manner on the adverse alterations in the oxidative stress              
induced by As​. The development of novel pharmaceutical delivery approaches of CUR may             
have higher efficacy compared to its conventional administration. ​CUR intervention may be a             
promising approach for the prevention of As-induced damage ​and should be tested in clinical              
studies. Therefore, CUR, a spice once associated with the kitchen shelf, will be promoted to               






Figure 1​. ​Structure of arsenic compounds​. 
Figure 2. Toxicity of Arsenic ​in different organs​. Abbreviations: micronucleus (MN),           
8-hydroxy-20deoxyguanosine (8-OHdG), p38 mitogen-activated protein kinase(MAPK),      
reactive oxygen species (ROS), oxidative stress (OS) 
Figure 3​. ​Molecular mechanism of arsenic toxicity in different organs​. Abbreviations:           
heme oxygenase 1 (HO-1), activation of activator protein-1 (AP-1), reactive oxygen species            
(ROS). 
Figure 4. Ameliorative effects of curcumin against arsenic-induced toxicity. Arsenic          
exposure leads to ROS generation which results in oxidative stress and deactivation of the              
cellular signaling pathway, and ultimately DNA damage, apoptosis and organ dysfunction.           
Curcumin reverses the arsenic-induced ROS generation and activates the antioxidant enzyme.           
Abbreviations: NAD(P)H:quinone oxidoreductase 1 (NQO1), GSTs, Gama-glutamylcysteine       
synthetase heavy subunit (γ-GCSh) and light subunit, heme oxygenase 1 (HO-1), nuclear            
factor (erythroid-2 related) factor 2(Nrf2), superoxide dismutase (SOD), catalase (Cat),          
glutathione peroxidase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST),        
and glucose-6-phosphate dehydrogenase (G6PD), reactive oxygen species (ROS), c-Jun         




Table 1. Effect of curcumin on arsenic induced-toxicity in different organs. 
Arm Experimental model Consequence Ref. 
Neurotoxicity 
NaAsO2(20 mg/kg BW; 28 
days) + CUR (100 mg/kg BW; 
28 days) 
-female Wistar rats  -​increase in the activity of GPx, SOD, GSH and 
decrease of MDA in frontal cortex, corpus striatum 
and hippocampus 
-increase of binding of striatal dopamine receptors 
and tyrosine hydroxylase  expression  
[163] 
NaAsO2 (20 mg/kg BW; 28 
days) + CUR(100 mg/kg BW; 
28 days) 
-female Wistar rats -elevated levels of catecholamines and their 
metabolites as well as serotonin 
-reduced levels of NO in brain regions 
[128] 
NaAsO2 (2 mg/kg) and ECNPs 
(1.5 or 15 mg/kg) 
-male Wistar 
rats 
-ameliorated alterations in hepatic OS markers and 
restoration of blood GSH 
[196] 
NaAsO2 (20 mg/kg BW) + CUR 
(100 mg/kg BW) 
-female Wistar rats -increased learning and memory execution related 
to over binding of [3H]-QNB and activity of AChE 
in hippocampus and frontal cortex  
-elevation of choline acetyltransferase and binding 
of cholinergic–MAChR, Nissl-stained 
hippocampus  
[186] 
As (20 mg/kg BW) +CUR (100 
mg/kg BW) 28 days 
-male rats of Wistar 
rat 
-defend against alterations in the mitochondrial 
membrane integrity, function of mitochondrial 
complexes and reduction in the CHRM2 receptor 
gene in specific brain regions together with 
regulating the amplification of brain pro- and 
anti-apoptotic proteins 
[188] 
NaAsO2 (20 mg/kg BW) +CUR 
(100 mg/kg BW) 28 days 
-male rats of Wistar 
rat 
-protection of arsenic-caused changes in the 
regulation of DAD2 receptors, pPP1α, PKA, 
pCREB, and pDARPP32 
-modulation in the regulation of pGSK3β and 
BDNF in corpus striatum  
[179] 
Genotoxic effects 




-decreasing the number of structural aberrations, 
and hypoploidy 
[154] 




-combating ROS production and lipid peroxidation 
-promotion the activities of numerous antioxidant 
enzymes i.e. Cat, SOD, GPx, GR, GST and GSH 
[122] 




- suppression of the 8-OHdG value and OGG1 
regulation 
-activation of DNA repair enzymes participated in 
the repair pathways at protein and genetic levels 
[155] 
NaAsO2 (25 ppm)+CUR-NP 
(100 mg/kg BW) 
-rat -attenuated chromosomal aberrations, micronuclei 
formation, DNA damage 
 
[156] 
NaAsO2 (500 µg/l)+ CUR(5, 10 
and 15 mg/kg BW/daily)  
-Normal male Swiss 
albino 
-prevented NaAsO2-induced DNA lesions through 
decreasing comet tail moment of whole blood and 
MN population in cultured spleenic lymphocytes 
[160] 
As2O3 (0.1, 0.2, 0.5, 1, 2.5, and 
5 mg/l)+ CUR( 1, 2, 5, 10, 20, 
and 50 µM) 
-neural precursor cells -promoted telomerase activity of neural 
stem/progenitor cells  
-decreased arsenic-created apoptosis (by 
inactivation of caspases) and-ROS generation 
[176] 
NaAsO2 (100, 250, 500 and 




-reduction in comet tail moment 
-quenching the OS 





As2O3 (4 mg/kg BW; 45 
days+CUR(15 mg/kg BW) 
-male Wistar rats -decrement in hepatic arsenic accumulation and 
serum marker enzymes including AST, ALT and 
ALP 
[195] 
As+ CUR -female Kunming 
mice 
-enhance arsenic methylation and urinary excretion 
-overexpression of hepatic Nrf2 protein and its 
downstream genes (NQO1 and HO-1) 
[125] 
As2O3(0.4 mg/kg BW) 
+CUR(0.4 mg/kg BW) 
-adult male Swiss 
Albino Mic 
- decreased intracellular ROS generation via 
promoting the activity of GSH generating enzyme 
GR and ROS scavenging enzymes (GST, GPx, 
SOD and Cat) in hepatic tissue  
[127] 
CUR-NP (100 mg/kg 
BW) 
-male Wistar rats -decreased LPO 
-increased the activities of SOD, Cat, GPx and GR 
in liver 
[197] 
NaAsO2(5 µM) + CUR (5 and 
10 µg/ml) 
-albino Swiss mice -mitigated the effects of arsenic on cell viability, 
ROS generation, loss in MTP, and hypodiploid 
DNA content  
[201] 
As(5 mg/kg BW)+ THC (80 
mg/kg BW) 28 days 
-male albino Wistar 
rats  
-decreased the levels of AST, ALT, ALP and LDH 
-increased the activities of membrane bound 
ATPases, enzymatic antioxidants including SOD, 
Cat, GPx, GST, GR and G6PD along with 
non-enzymatic antioxidants like reduced GSH, 
total SH-groups, vitamins C and E.  
[203] 
As2O3 (5 mg/kg BW) +THC 
(80 mg/kg BW) 
-adult male albino 
Wistar rats 
-decreased values of AST, ALT, ALP and bilirubin [202] 
Oxidative damage 
As2O3 (5 mg/kg BW) +CUR 
(15 mg/kg BW)  
-​ male 
Sprague–Dawley rats 
- reduced the induction in the levels of TBARS  
-induced the reduction in the activities of 
antioxidant enzymes  and the SH-groups levels  
[148] 
As2O3 (25 ppm)+CUR-NP(100 
mg/kg)  
-male Wistar rats -elevated the GSH level in renal and brain  
-enhanced GR function in renal and brain tissues  
-reduced the LPO 
[135] 
- As2O3 (8 mg/kg)+CUR( 0, 
100, 150, or 200 mg/kg) 
-​female Kunming 
mouse 
- elevate SOD  
-decrease ROS and MDA in the ovary 
-abrogating both higher value of atretic follicles       
and suppression of granular cells proliferation      
under OS  




NaAsO2 (5 mg/kg)+CUR(100 
mg/kg) 
-​ ​adult male NMRI 
mice 
-increase the diameter of glomerulus and proximal 
tubule, glomerular area, total antioxidant capacity  
-decrease serum concentration of MDA 
[134] 
    
As2O3+​ Curcuma 
aromatic(​50 mg/kg BW) 
-​ male Wistar​ albino 
rats 
-increament of the serum level of uric acid, 
blood urea nitrogen, and creatinine because of 
renal dysfunction 
-normalization of the serum levels of uric acid, 
blood urea nitrogen and creatinine 
[137] 
As2O3(5 mg/kg BW)+ CUR (15 
mg/kg BW) 
-male Wistar rats -mitigates the elevation of liver function enzymes, 
lipid and protein profile, and 





iAs (30 ​𝜇​M) + CUR(20 ​𝜇​M)  -human keratinocytes 
(HaCaT cells) 
-elevated the viability of HaCaT cells  
-mitigated Asi-induced transcription of cleaved 
caspase-3 and PARP 
[126] 
Other pathologies 
As (20 ppm)+ CUR(100 mg/kg 
BW) 
-adult male Wistar 
rats 
- inhibit arsenic-related apoptosis in rat thymocytes 
by its free radical scavenging 
[211] 
CUR-NP (100 mg/kg BW) + 
As2O3 (25 ppm)  
-male Wistar rats -decreased the spleen weight  
-increased the splenic lymphocyte proliferation 
- induced type hypersensitivity response and 
secondary antibody response to specific antigen  
[129] 
Abbreviations​: alanine transaminase (ALT), alkaline phosphatase (ALP), arsenic (As), aspartate transaminase (AST), body             
weight (BW), catalase (Cat), curcumin (CUR), encapsulated curcumin nanoparticles (ECNPs), ​glucose-6-phosphate           
dehydrogenase (G6PD)​, glutathione (GSH), glutathione peroxidase (GPx), glutathione reductase (GR),          
glutathione-S-transferase (GST)​, heme oxygenase-1 (HO-1), inorganic arsenic (iAs), ​lactate dehydrogenase          
(LDH)​,lipid peroxidation (LPO), Malondialdehyde (MDA), Micronucleus (MN), mitochondrial transmembrane potential          
(MTP), muscarinic receptors (MAChR), NADP(H) quinine oxidoreductase 1 (NQO1), nanoparticles encapsulated curcumin            
(CUR-NP), oxidative stress (OS), ​sulfhydryl groups (SH-groups)​, superoxide dismutase (SOD), tetrahydrocurcumin           
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